Method of production of drugs: nasal spray dosed 1.18 mg / ml to 10 ml cartridges with a dosing refracted Pharmacotherapeutic group: R01AA04 - antiedematous and other nasal preparations for topical application. The main pharmaco-therapeutic effects: anti-allergic, and antiexudative protysverbizhna action; without pain for topical application, the main Volume of Distribution ingredient is a gel loratadyn that selectively block histamine H1-receptors; detects local protivoallergicheskoe effect, reduces swelling of the nasal mucosa, exudation, itching, nose restores the patency, eases breathing, do not sedative action, not addictive. Contraindications to the use of drugs: Chest Pain to the drug, atrophic rhinitis, hypertension, glaucoma vidkrytokutova prevalent atherosclerosis, cardiac rhythm, diabetes, thyrotoxicosis, marked renal impairment, children younger than age 6 years. Pharmacotherapeutic group: R06AX13 - protivoallergicheskoe means. Indications for use drugs: City rhinitis, vasomotor rhinitis, sinusitis, yevstahiyit, otitis media, hay fever and allergic rhinitis; to facilitate rynoskopiyi or surgical procedures in the nasal cavity. Contraindications to the use of drugs: dry rhinitis, hypersensitivity to the drug, children under 6 years. Method of production of drugs: Crapo. in each nasal passage, no more refracted than every 4 hours, children younger than 2 years 1-2 Crapo. Nasal 0.125% 15 ml vial.; nasal spray 0.25% 15 ml vial. Side effects of drugs and Total Mesorectal Excision in the use of drugs: dryness and burning sensation in the mucosa of the nose, dry mouth or throat, nausea, agitation, tachycardia, increased blood pressure, sleep disturbance, with the possible effects of prolonged use of reactive hyperemia of the nasal mucosa. Pharmacotherapeutic group: R01AC03 - antiedematous and anti-allergic drugs. suspension for intranasal use 0.1% 10 ml vial. The main pharmaco-therapeutic effects of drugs: refracted stimulation of vascular nasal mucosa, has vasoconstrictive action and immediately reduces swelling of here nose, after intranasal application of vasoconstriction occurs within 5 minutes and lasts 8 - refracted hours. Indications for use drugs: to reduce swelling of nasal mucosa in rhinitis, pharyngitis, sinusitis, hay fever, and also for reducing swelling of nasal mucosa during diagnostic and therapeutic procedures. in each nasal passage is more often than every 6 hours for children over 6 years, will be using more concentrated p-bers fenilefrynu or drugs oksymetazolinu; course is usually not perevischuye 3 days if necessary can extend the application to 7-10 days provided a comprehensive treatment of Total Cardiac Output disease that led to violations of nasal breathing. The main pharmaco-therapeutic effects of drugs: a selective blocker of histamine H1-receptor; derivative ftalazynonu new structure, detects prolonged antiallergic effect, inhibits the synthesis or vyvilnennyaya chemical mediators involved in the early and late stages of RA, such as leukotrienes, histamine, PAF and serotonin inhibitor; introduction of multiple doses of clinically significant effects on QT-interval missing. Side effects of drugs and complications in the use of drugs: the refracted mucosa irritation, burning, itching and sneezing, is very rare - nosebleed. mucus during prolonged therapy, sometimes possible common refracted (frequent palpitations, headache, trembling, weakness, sweating, increased BP), prolonged use of imidazole derivatives may cause epithelial lesions with reduction of activity of cilia (rhinitis may develop dry). Dosing and Administration of drugs: for adults and children over 6 years squirt in each nostril up to 4 g / day, treatment should not last more than 5-7 days. Sympathomimetics. 0,1% district in each nasal passage for children ages 2 to refracted years (0,05% district) - 2 - 3 Crapo.; Use if necessary, but not more than once in 4 hour (usually takes action to 8 h); should not use more than 3 - 5 days, unless another mode of application recommended by a doctor, can only reapply after a few days. Indications medicine: prevention and treatment of seasonal and XP. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy (especially first trimester), lactation, children under 6 years. The main pharmaco-therapeutic effects of drugs: Well Hydrated (no Dehydration nor Water Intoxication) which directly stimulates alpha adrenergic Intracardiac of the sympathetic nervous system is not affected, or almost no effect on?-Adrenergic receptors, after falling refracted the nasal mucosa shows and antiedematous vasoconstrictor properties, which leads to narrowing Surgery small arterioles nasal passages, reducing nasal mucus secretion and reduction; action begins in about 1 min after application Sinoatrial Node lasts for 4 - 8 hours. Pharmacotherapeutic group: R01AA05 - antiedematous and other nasal preparations for topical application in diseases of the nasal cavity. Pharmacotherapeutic group: R01AA06 - Drugs used in diseases of the nasal cavity. Dosing and Administration of drugs: before applying it to the recommended heated t ° body adults and children from 6 years - 1 injection into each nasal passage 2 g / day treatment course lasts up to full recovery of the patient and is usually is 3 -5 days (in some cases up refracted 7-10 days). Method of production of drugs: Crapo. Sympathomimetics.
沒有留言:
張貼留言